These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17683281)

  • 1. Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design.
    Cardoso I; Almeida MR; Ferreira N; Arsequell G; Valencia G; Saraiva MJ
    Biochem J; 2007 Nov; 408(1):131-8. PubMed ID: 17683281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation inhibits amyloid fibril formation of transthyretin.
    Maleknia SD; Reixach N; Buxbaum JN
    FEBS J; 2006 Dec; 273(23):5400-6. PubMed ID: 17116243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
    Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P
    J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of amyloidogenic transthyretin to the plasma membrane alters membrane fluidity and induces neurotoxicity.
    Hou X; Richardson SJ; Aguilar MI; Small DH
    Biochemistry; 2005 Aug; 44(34):11618-27. PubMed ID: 16114899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
    Green NS; Palaninathan SK; Sacchettini JC; Kelly JW
    J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.
    Ferreira N; Cardoso I; Domingues MR; Vitorino R; Bastos M; Bai G; Saraiva MJ; Almeida MR
    FEBS Lett; 2009 Nov; 583(22):3569-76. PubMed ID: 19861125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
    Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
    FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
    Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
    Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
    Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
    J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
    Lashuel HA; Lai Z; Kelly JW
    Biochemistry; 1998 Dec; 37(51):17851-64. PubMed ID: 9922152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?
    Zhang Q; Kelly JW
    Biochemistry; 2005 Jun; 44(25):9079-85. PubMed ID: 15966731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sequence-dependent unfolding pathway plays a critical role in the amyloidogenicity of transthyretin.
    Yang M; Yordanov B; Levy Y; Brüschweiler R; Huo S
    Biochemistry; 2006 Oct; 45(39):11992-2002. PubMed ID: 17002298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
    Dolado I; Nieto J; Saraiva MJ; Arsequell G; Valencia G; Planas A
    J Comb Chem; 2005; 7(2):246-52. PubMed ID: 15762752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.
    Trivella DB; Bleicher L; Palmieri Lde C; Wiggers HJ; Montanari CA; Kelly JW; Lima LM; Foguel D; Polikarpov I
    J Struct Biol; 2010 Jun; 170(3):522-31. PubMed ID: 20211733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils.
    Redondo C; Damas AM; Olofsson A; Lundgren E; Saraiva MJ
    J Mol Biol; 2000 Dec; 304(3):461-70. PubMed ID: 11090287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.
    Hurshman AR; White JT; Powers ET; Kelly JW
    Biochemistry; 2004 Jun; 43(23):7365-81. PubMed ID: 15182180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture.
    Sörgjerd K; Klingstedt T; Lindgren M; Kågedal K; Hammarström P
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1072-8. PubMed ID: 18983977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of the transthyretin molecule as a key factor in the interaction with a-beta peptide--relevance in Alzheimer's disease.
    Ribeiro CA; Saraiva MJ; Cardoso I
    PLoS One; 2012; 7(9):e45368. PubMed ID: 23028965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.